STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

Bibliografiska uppgifter
Huvudupphovsmän:	Walton, R, Russell, R, Alberti, K, Clark, M, Potts, J, Bisaz, S, Fleisch, H
Materialtyp:	Journal article
Språk:	English
Publicerad:	1974

Liknande verk

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
av: Walton, R, et al.
Publicerad: (1974)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
av: Walton, R, et al.
Publicerad: (1975)

Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
av: Walton, R, et al.
Publicerad: (1976)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
av: Russell, R, et al.
Publicerad: (1979)

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
av: Smith, R, et al.
Publicerad: (1973)

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
av: Russell, R, et al.
Publicerad: (1975)

ABNORMAL RESPONSES TO EHDP TREATMENT OF PAGETS-DISEASE
av: Smith, R, et al.
Publicerad: (1977)

Diphosphonates in Paget's disease.
av: Russell, R, et al.
Publicerad: (1974)

Diphosphonates and polyphosphates in medicine
av: Russell, R
Publicerad: (1975)

Synthesis of Four Enantiomers of (1-Amino-3-Hydroxypropane-1,3-Diyl)Diphosphonic Acid as Diphosphonate Analogues of 4-Hydroxyglutamic Acid
av: Liwia Lebelt, et al.
Publicerad: (2022-04-01)

Microstructure and Phase Characterization of Alkali-Activated Slag–Fly Ash Materials with Tetrasodium of 1-Hydroxy Ethylidene-1, 1-Diphosphonic Acid (HEDP·4Na)
av: Bo Zhou, et al.
Publicerad: (2024-05-01)

Treatment of myositis ossificans progressiva with a diphosphonate.
av: Russell, R, et al.
Publicerad: (1972)

Complexation of 1-Hydroxyethylidene-1,1-Diphosphonic Acid (HEDP) and Manganese(II) in Aqueous Solution
av: О.V. Bogatyrev, et al.
Publicerad: (2016-03-01)

Proceedings: Background to the use of diphosphonates as bone scanning agents.
av: Russell, R, et al.
Publicerad: (1975)

Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
av: Gray, R, et al.
Publicerad: (1987)

Treatment of [99mTc]Tc‐hydroxy‐diphosphonate ([99mTc]Tc‐HDP) extravasation using hyaluronidase
av: Kevin R. Doornhof, et al.
Publicerad: (2024-08-01)

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats
av: Russell, R, et al.
Publicerad: (1970)

Diaquabis{[1-hydroxy-2-(1H-imidazol-3-ium-1-yl)ethane-1,1-diyl]bis(hydrogen phosphonato)}manganese(II)
av: Yu Zhang, et al.
Publicerad: (2009-12-01)

1-(5-Hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethan-1-one
av: Bingjing Liu, et al.
Publicerad: (2010-06-01)

catena-Poly[zinc(II)-&#956;3-{hydrogen [1-hydroxy-2-(3-pyridinio)ethane-1,1-diyl]diphosphonato}]
av: Xihe Huang, et al.
Publicerad: (2010-01-01)

Impact and mechanism of bisphosphonate depressant 1-hydroxypropane-1,1-diphosphonic acid on flotation decalcification of dolomite-rich magnesite ore
av: Wengang Liu, et al.
Publicerad: (2024-07-01)

1-Phenyl-1-[(1-phenylethyl)sulfonylmethylsulfonyl]ethane
av: Jing-tao Liu, et al.
Publicerad: (2009-12-01)

Hyperphosphatemia and Cardiovascular Disease
av: Chao Zhou, et al.
Publicerad: (2021-03-01)

Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1
av: Hualong Zang, et al.
Publicerad: (2024-01-01)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
av: Ju-Young Moon, et al.
Publicerad: (2015-03-01)

Synthesis and structure of heterometallic multiligand Ge(IV) - 3d-metals complexes with 1-hydroxyethane-1,1-diphosphonic acid and 1,10-phenanthroline
av: Kyrylo Tsymbaliuk, et al.
Publicerad: (2024-12-01)

Crystal structure of 1-(6-hydroxy-2-phenylbenzofuran-5-yl)ethan-1-one, C16H12O3
av: Olomola Temitope O., et al.
Publicerad: (2020-10-01)

1-(Pyrrolidin-1-yl)ethan-1-iminium chloride
av: Rylan Artis, et al.
Publicerad: (2023-09-01)

Disodium 4,5,6-trihydroxybenzene-1,3-disulfonate dihydrate
av: U. Beginn, et al.
Publicerad: (2010-10-01)

Crystal structure of 1-(4-chloro-2-hydroxy-5-iodophenyl)ethan-1-one, C8H6ClIO2
av: Mphahlele Malose J.
Publicerad: (2019-12-01)

Crystal structure of (E)-1-(2-hydroxy-3-{[2-hydroxybenzylidene]amino}phenyl)ethan-1-one, C15H13NO3
av: Yang Yu-Hua, et al.
Publicerad: (2017-11-01)

Clinical Characteristics and Outcomes of Hyperphosphatemia in Patients with Chronic Kidney Disease Stages 1–2
av: Chao Xie, et al.
Publicerad: (2024-07-01)

Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy
av: Walton, K, et al.
Publicerad: (1985)

Hyperphosphatemia in chronic kidney disease
av: S. A. Martynov, et al.
Publicerad: (2019-10-01)

Optimizing 1-hydroxyethylidene-1,1-diphosphonic acid and mechanically-activated iron ore tailings to prepare low-cost and retarded magnesium oxysulfate cement
av: Huihui Liang, et al.
Publicerad: (2022-12-01)

New amino bisphosphonate compound for skeletal imaging: Comparison study with methylenediphosphonic acid (MDP) and (1-hydroxyethane-1,1-diyl) diphosphonic acid (HEDP)
av: Assaad Thaer
Publicerad: (2016-03-01)

3,3′-[(1E,1′E)-Hydrazine-1,2-diylidenebis(ethan-1-yl-1-ylidene)]bis(4-hydroxy-6-methyl-2H-pyran-2-one)
av: Abouelhaoul El Alami, et al.
Publicerad: (2019-10-01)

(E)-1-(4-Bromophenyl)ethan-1-one semicarbazone
av: Hoong-Kun Fun, et al.
Publicerad: (2009-07-01)

(E)-1-(4-Fluorophenyl)ethan-1-one semicarbazone
av: Hoong-Kun Fun, et al.
Publicerad: (2009-07-01)

Preparation of anti-reversion agent disodium hexamethylene-1,6-dithiosulfate dihydrate
av: LI Tian-yu1, HOU Wen-jie2, SHI Yun-hai1, YU Tao1
Publicerad: (2024-01-01)